High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
Open Access
- 15 August 2006
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 108 (4), 1291-1297
- https://doi.org/10.1182/blood-2006-02-003996
Abstract
Regulatory T cells (Tregs) that constitutively express FOXP3 are instrumental to the maintenance of tolerance and may suppress graft-versus-host disease (GVHD) in humans. To determine whether regulatory T cells in allogeneic stem cell transplants (SCTs) ameliorate GVHD after transplantation, we quantitated the coexpression of FOXP3 on CD4+ T cells in 32 donor SCTs infused into HLA-matched siblings and examined GVHD incidence in respective recipients. High CD4+FOXP3+ T-cell count in the donor was associated with a reduced risk of GVHD. We monitored Tregs during immune reconstitution in 21 patients with leukemia undergoing a T-cell–depleted allogeneic SCT. Early after SCT, there was a significant expansion in the CD4+FOXP3+ T-cell compartment. A low CD4+FOXP3+ T-cell count early after SCT (day 30) was associated with an increased risk of GVHD, and the ratio of CD4+FOXP3+ T cells to CD4+CD25+FOXP3– T cells was significantly reduced in patients with GVHD, suggesting diminished control of effector T cells. Our findings suggest that graft Treg content may predict for risk of GVHD after SCT. Determining the Treg levels in the donor and manipulating Tregs early after transplantation may provide a new approach to controlling GVHD.Keywords
This publication has 50 references indexed in Scilit:
- Association of Foxp3 regulatory gene expression with graft-versus-host diseaseBlood, 2004
- Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantationTransplantation and Cellular Therapy, 2004
- Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsBlood, 2004
- Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantationBone Marrow Transplantation, 2003
- Regulatory T cells in transplantation toleranceNature Reviews Immunology, 2003
- Regulatory T cells under scrutinyNature Reviews Immunology, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- CD4+CD25+ Immunoregulatory T CellsThe Journal of Experimental Medicine, 2002
- Infectious ToleranceThe Journal of Experimental Medicine, 2002
- Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblingsBlood, 2002